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CASE PRESENTATION
A 54-year-old white female with a past history of
hypothyroidism and smoldering multiple myeloma (MM)
presented with the new onset of severe nephrotic
syndrome and acute renal failure. She had been diagnosed
2 years earlier with stage IA MM following traumatic
fractures of the pelvis and right hip. At that time, she was
found to have an immunoglobulin G (IgG)-k serum
monoclonal (‘M’) spike of 4.02 g/dl, bone marrow biopsy
showed 60–70% plasmacytosis and skeletal survey was
negative for lytic lesions. Blood urea nitrogen was 20 mg/dl
(7.1 mmol/l) (normal range, 7–25 mg/dl (2.5–8.9 mmol/l)),
serum creatinine was 1.0 mg/dl (88mmol/l), serum calcium
was normal and 24 h urinary protein was 279 mg/day.
Following evaluation at two major myeloma treatment
centers, it was decided that no specific therapy was needed.
Five months after diagnosis, urine protein excretion was
467 mg/day. Osteopenia of the lumbar spine was noted 7
months after the diagnosis of myeloma and she was started
on pamidronate 90 mg intravenous monthly. Three months
after the initiation of pamidronate therapy, the patient’s
serum creatinine rose progressively to 1.5–1.6 mg/dl
(133–141mmol/l) with a decline in serum albumin from 3.5
to 2.5 g/dl (35–25 g/l) (normal range, 4.1–5.3 g/dl (41–53 g/l)).
She developed periorbital and lower extremity edema
accompanied by the new appearance of nephrotic range
proteinuria (14 g/day). Serum creatinine continued to
increase to 3.9 mg/dl (345mmol/l) 1 month later. At this
time, she was found to have a rising serum monoclonal ‘M’
spike and was started on cyclic dexamethasone (40 mg
daily for 4 days every 3 weeks for six cycles), cyclopho-
sphamide, thalidomide 100 mg daily and bortezomib. She
was referred for nephrologic evaluation of severe nephrotic
syndrome and acute renal failure.
Physical examination revealed a well-developed,
well-nourished female with a blood pressure of
180/90 mmHg, pulse 68/min and no jugular venous
distention. The heart was regular in rate and rhythm and a
II/VI systolic ejection murmur was detected at the left
sternal border. The lungs were clear to auscultation. The
abdomen was soft and non-tender. There was no
organomegaly. There was 3þ pitting edema in the lower
extremities.
Laboratory data on presentation were as follows:
hematocrit, 35.6% (normal range, 35–47%); blood urea
nitrogen 30 mg/dl (10 mmol/l); serum creatinine, 3.9 mg/dl
(345mmol/l); creatinine clearance 18 cm3/min; 24-h urine
protein, 14 400 mg; total serum protein, 8.2 g/dl (82 g/l)
(normal range, 6.3–8.2 g/dl (63–82 g/l)); serum albumin,
2.9 g/dl (29 g/l); and serum bicarbonate 29 mM/l (normal
range, 25–32 mM/l). Urinalysis revealed 4þ protein and
3þ heme, with normal pH and negative glucose. Serum
sodium, potassium, chloride, calcium, phosphorus and uric
acid were normal. Quantitated serum immunoglobulins
(Ig) included reduced serum IgA o7 mg/dl (o0.07 g/l)
(normal range, 70–350 mg/dl (0.7–3.5 g/l)); reduced serum
IgM 9.6 mg/dl (0.096 g/l) (normal range, 50–300 mg/dl
(0.5–3 g/l)); and markedly elevated serum IgG 3540 mg/dl
(35.4 g/l) (normal range, 700–1700 mg/dl (7–17 g/l)). Serum
immunofixation revealed an IgG-k ‘M’ spike. A renal
biopsy was performed.
RENAL BIOPSY FINDINGS
Light microscopic examination disclosed one core of renal
cortex and medulla. There were nine glomeruli, two of which
were globally sclerotic. Four glomeruli displayed global
collapsing sclerosis with luminal occlusion owing to acute
wrinkling and retraction of glomerular basement membranes
with marked hypertrophy and hyperplasia of the overlying
podocytes (Figure 1a). The swollen podocytes crowded the
urinary space and contained focal intracytoplasmic periodic
acid-Schiff stain-positive protein resorption droplets as well
as abundant globally distributed intracytoplasmic crystals
that stained periodic acid-Schiff stain negative and tri-
chrome-red (Figure 1b). The remaining three glomeruli
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without collapsing features also displayed diffusely swollen
podocytes containing intracytoplasmic periodic acid-Schiff
stain-negative, trichrome-red inclusions. The tubules con-
tained focal large angulated crystalline casts forming
rhomboidal and triangular shapes (Figure 1c). There was
focal mononuclear cell reaction to the casts, but no giant cell
formation. Many proximal tubular cells also contained
abundant smaller intracytoplasmic crystals that stained
trichrome-red and ranged from rounded to angulated.
Approximately 40% of the cortex had tubular atrophy and
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Figure 1 | (a) There is global collapse of the glomerular capillary walls with marked hypertrophy and hyperplasia of overlying podocytes
(Jones methenamine silver with methyl green counterstain, original magnification 400). (b) The swollen podocytes contain abundant
trichrome-red intracytoplasmic inclusions (original magnification 400). (c) The tubules contain numerous brightly eosinophilic angular geometric
casts with adherent monocytes (hematoxylin and eosin, original magnification 400). (d) Immunofluorescence staining for k shows 3þ positivity
in the angular tubular casts, with negativity for l (not shown) (original magnification 400). (e) Immunohistochemical staining for k light chain
performed on paraffin sections highlights the podocyte inclusions. Staining for l was negative (not shown) (original magnification 400).
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interstitial fibrosis accompanied by a mild interstitial
infiltrate of monocytes and lymphocytes. There was mild
arterio- and arteriolosclerosis.
By electron microscopy, the glomerular capillary lumina
were focally obliterated by collapsing sclerosis with tight
wrinkling and retraction of glomerular basement membranes
accompanied by marked hypertrophy and hyperplasia of the
overlying podocytes. The podocytes contained abundant
intracytoplasmic crystals forming sharp-edged geometric
shapes within membrane-bound vesicles (Figure 2a). No
typical immune-type electron-dense deposits were identified
within the glomerular tuft. Overlying the collapsed segments,
there was podocyte detachment with complete foot process
effacement and intervening layering of loosely woven base-
ment membrane material. Similar intracellular electron-
dense crystals were identified throughout the proximal
tubular cytoplasm (Figure 2b). In addition, some tubules
contained large intraluminal crystalline casts with fractured
and angulated contours (Figure 2b).
Immunofluorescence showed strong (3þ ) staining of the
tubular casts for k light chain, with negativity for l light
chain (Figure 1d). Weak segmental glomerular tuft staining
for IgM and C3 was seen in one of the six glomeruli
present. Staining for IgG, IgA, C1q, fibrin, and albumin was
negative. The glomerular and tubular intracellular crysta-
lline inclusions failed to stain by immunofluorescence
performed both on frozen sections and on pronase-digested,
paraffin sections. However, the intracellular crystals stained
strongly for k light chain (with negativity for l) on paraffin
sections stained by the avidin–biotin immunoperoxidase
method following antigen retrieval using citrate buffer
(Figure 1e).
PATHOLOGIC DIAGNOSIS
1. Collapsing focal segmental glomerulosclerosis (FSGS),
severe, (pamidronate-associated).
2. Myeloma cast nephropathy, k light-chain type.
3. Abundant intracellular crystalline inclusions of k light
chain in tubular epithelial cells and podocytes.
CLINICAL FOLLOW-UP
Following the renal biopsy, pamidronate was discontinued
and the patient’s renal function gradually improved. Three
months after the renal biopsy, serum creatinine decreased to
3.0 mg/dl (265 mmol/l) and 24 h urinary protein excretion
decreased to 3.2 g/day. Four months after the renal biopsy,
the patient received high-dose melphalan and an autologous
stem cell transplant. Two months following stem cell
transplant, serum creatinine had fallen to 2.5 mg/dl
(221 mmol/l) and the patient had achieved a ‘90% remission’
of her myeloma with reduction in serum ‘M’ spike to 0.4 g/dl
and no detectable free urinary light chains. Two and one-half
years following stem cell transplant, serum creatinine is
1.8 mg/dl (159 mmol/l), 24 h urine protein is 600 mg and
serum IgG is 1010 mg/dl (10.1 g/l) with normal serum IgA
and IgM.
DISCUSSION
Renal involvement is common in MM. The incidences of
renal failure and proteinuria at presentation are 22–56% and
88%, respectively.1,2 The most common pattern of renal
parenchymal disease associated with MM is myeloma cast
nephropathy. Less frequent renal lesions include amyloidosis,
monoclonal immunoglobulin deposition disease, light-chain
Fanconi syndrome, type I cryoglobulinemic glomerulo-
nephritis, and immunotactoid glomerulonephritis. Other
potential renal complications in this patient population
include nephrocalcinosis, uric acid nephropathy, contrast
nephropathy, pyelonephritis, and obstructive uropathy. In
recent years, there has been increasing recognition of a
spectrum of nephrotoxicity associated with bisphosphonates,
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Figure 2 | (a) The swollen podocytes are engorged with numerous electron-dense intracytoplasmic crystalline inclusions. There is
complete effacement of foot processes and wrinkling and retraction of the glomerular basement membrane (original magnification 2000).
(b) Tubules contain crystalline fractured casts with sharp edges. Crystalline intracytoplasmic inclusions are also seen within the adjacent tubular
epithelial cells (arrow) (original magnification 2000).
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which are widely prescribed agents for treatment of MM-
associated hypercalcemia.3–11
Pamidronate is a bisphosphonate that inhibits bone
resorption through physicochemical and intracellular effects
including direct binding to calcium phosphate crystals within
bone matrix, resulting in suppression of osteoclast activity;
and inhibition of the mevalonate biosynthetic pathway
required for cholesterol production and protein prenylation,
resulting in loss of osteoclast function and induction of
apoptosis. We previously reported the association between
pamidronate and collapsing FSGS.3 Our initial cohort
consisted of seven patients who presented with nephrotic
syndrome and renal failure while undergoing long-term
treatment with pamidronate. The renal biopsies showed
collapsing FSGS and diffuse tubular injury. All seven patients
were elderly, Caucasian, and HIV negative. Five of these seven
patients received pamidronate at higher than the recom-
mended dose of 90 mg monthly. Of the three patients in
whom pamidronate was discontinued after the biopsy, two
had subsequent mild decreases in serum creatinine. Similar
to other forms of collapsing FSGS, our cases of pamidronate-
associated collapsing FSGS were characterized by increased
podocyte proliferation index and decreased expression of
synaptopodin, suggesting a mechanism of direct podocyte
toxicity. Since our initial report in 2001, we have encountered
more than 10 additional cases of collapsing FSGS following
treatment with pamidronate. In one noteworthy case, the
patient’s renal function improved after pamidronate was
discontinued and worsened following reintroduction of the
offending agent.6 Additional cases of pamidronate-induced
collapsing FSGS have been reported by others.7,8 The
spectrum of pamidronate nephrotoxicity also includes non-
collapsing forms of FSGS, minimal change disease, and
tubulointerstitial nephritis.4,9–11
Histologically, myeloma cast nephropathy exhibits dis-
tinctive distal tubular casts and diffuse tubular injury. The
casts have a hard, fractured, crystalline appearance and
typically stain strongly eosinophilic negative with the
periodic acid-Schiff stain, and polychromatic with the
trichrome stain. The casts are frequently surrounded by
mononuclear and giant cell reaction. Uncommonly, myeloma
cast nephropathy is associated with crystalline inclusions
within the cytoplasm of tubular epithelial cells which, when
present in proximal tubules, may be associated with Fanconi
syndrome.12 Despite the presence of focal tubular epithelial
crystals, the patient presented here had no clinical evidence of
Fanconi syndrome. By contrast, the entity of light-chain
Fanconi syndrome manifests predominantly intracytoplasmic
crystals within proximal tubules.13 In this condition, the k
light chain is typically of the V1 subgroup, which is
particularly resistant to proteolysis.13
Light-chain crystalline inclusions within podocytes are
extremely rare. In our review of the English literature, we
found only seven reported cases14–20 (Table 1). The seven
cases include four males and three females, with a mean age
of 53.3 years (range, 40–71 years). The crystals were
associated with IgG-k MM in six of the cases and with
IgG-k ‘monoclonal gammopathy of unknown significance’ in
Table 1 | Main features of seven previously reported cases of crystalloid inclusions in podocytes associated with plasma cell
dyscrasia
Reference
Sex/age
(years)
Plasma cell
dyscrasia
Renal clinical/pathologic
features
Distribution of crystals in
the kidney
Staining of intracytoplasmic
crystals by IF/IHC
Carstens and
Woo14
Male/57 IgG-k myeloma Renal insufficiency,
subnephrotic proteinuria
Podocytes, lesser degree in
MCs, PECs, TECs
IF: Negative for both k and l
Yamamoto
et al.15
Male/71 IgG-k myeloma,
systemic crystal
storing
histiocytosis
Proteinuria (40% Bence–Jones
protein)
Interstitial histiocytes,
podocytes, lesser degree in
PECs
IHC: Positive for k and g heavy
chain (performed on the cornea)
Matsuyama
et al.16
Female/40 IgG-k MGUS Nephrotic syndrome, renal
failure (FSGS on renal biopsy)
Podocytes, lesser degree in
PECs, TECs, tubular lumina
IHC: Positive for k; negative for l
Kowalewska
et al.17
Female/52 IgG-k myeloma Renal insufficiency, mild
proteinuria
Podocytes, PECs, lesser
degree in TECs, interstitial
monocytes
IF: Negative for both k and l
IHC: Positive for k; negative for l
Papla et al.18 Male/51 IgG-k myeloma,
systemic crystal
storing
histiocytosis
Bence–Jones proteinuria Interstitial histiocytes,
podocytes, MCs, endothelial
cells
IHC: Negative for both k and l
(performed on bone marrow)
Tomioka
et al.19
Female/46 IgG-k myeloma Renal insufficiency, albuminuria Podocytes, TECs, Interstitial
histiocytes
IF: Positive for IgG-k; negative
for l
Keller et al.20 Male/56 IgG-k myeloma Acute renal failure
(acute tubular necrosis on
renal biopsy)
Podocytes, TECs, interstitial
macrophages, tubular
lumina
IF: Negative for both k and l
Current case Female/54 IgG-k myeloma Renal insufficiency, nephrotic
syndrome (collapsing FSGS
and myeloma cast nephropathy
on renal biopsy)
Proximal TECs, podocytes,
tubular casts
IF: Negative for both k and l
IHC: Positive for k; negative for l
IF=immunofluorescence; IHC=immunohistochemistry; k=kappa light chain; l=lambda light chain; MCs=mesangial cells; MGUS=monoclonal gammopathy of unknown
significance; PECs=parietal epithelial cells; TECs=tubular epithelial cells.
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one. In two of the six cases associated with MM, systemic
features of the rare entity ‘crystal storing histiocytosis’ were
present. Six patents presented with proteinuria, and full
nephrotic syndrome was present in one case in which FSGS
was seen on renal biopsy examination. Renal insufficiency
was present in five cases. In all seven cases, similar inclusions
also involved other renal parenchymal cells such as parietal
epithelial cells, tubular epithelial cells, and/or interstitial
histiocytes. Importantly, positive staining for k light chain by
immunofluorescence was found in only one of the four cases
studied,19 whereas the other three stained successfully for k
light chain using the avidin–biotin immunoperoxidase
method.15–17 Similar to our report, the crystals in the case
described by Kowalewska et al.17 failed to stain by immuno-
fluorescence, but stained for k by immunohistochemistry on
paraffin tissue. Based on the findings in our case and the
previously reported cases, it appears that immunohisto-
chemistry on paraffin sections is a more sensitive technique
for characterization of the intracellular crystals owing to its
reliance on antigen retrieval, which promotes the denatura-
tion of cell membranes or lysosomes and the opening out of
antigenic sites that may be sequestered within the crystalline
lattice. The negative staining of the intracellular crystals by
immunohistochemistry in the case reported by Papla et al.18
may have been due to partial degradation of the light chains
or inaccessibility of the epitopes to antibody binding owing
to their highly crystallized state.
In summary, we describe the unique case of a 54-year
female with IgG-k MM who presented with nephrotic
syndrome and renal insufficiency while on pamidronate
therapy. Renal biopsy revealed three related but distinct
processes – pamidronate-associated collapsing FSGS, mye-
loma cast nephropathy and intracellular crystalline inclusions
in podocytes and tubular cells. The improvement in renal
function and proteinuria following withdrawal of pamidro-
nate supported the diagnosis of pamidronate nephrotoxicity,
and renal parameters continued to improve following
chemotherapy and autologous stem cell transplant. Based
on the simultaneous occurrence of these three processes, it
appears likely that pamidronate-induced collapsing FSGS
potentiated the precipitation of the tubular casts and
intracellular crystals by causing direct tubular epithelial
toxicity as well as indirect tubular injury through protein
overload. Both of these pathomechanisms may have impaired
the proximal tubule’s ability to reabsorb and catabolize
filtered light chains. Similarly, the intracytoplasmic accumu-
lation of crystals within podocytes was likely favored by the
combined effects of pamidronate-induced podocyte toxicity,
the resulting glomerular permeability defect causing in-
creased intrapodocyte trafficking of filtered protein, and the
innate resistance of the particular monoclonal k light chain
to proteolysis.
This case illustrates that pamidronate nephrotoxicity
typically manifests with collapsing FSGS and combined
podocyte and tubular epithelial cell toxicity. Pamidronate
nephrotoxicity must be considered in the differential
diagnosis of nephrotic syndrome and acute renal failure
occurring in the patient with MM. In the patient with
myeloma cast nephropathy, tubular intracytoplasmic light-
chain inclusions are infrequent and not always associated
with Fanconi syndrome.
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